Abstract
We report the case of a BMT recipient who developed blindness 2½ months after BMT. Microvascular retinopathy, cortical blindness and other ocular pathologies were excluded with appropriate tests. Electrophysiological studies showed retinal damage without excluding an optic nerve lesion. The patient, who had several risk factors for neurologic-induced cyclosporine toxicity, improved with cyclosporine withdrawal. Our findings stress the need of electrophysiological tests to exclude neuroretinal damage in patients receiving cyclosporine after BMT.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
López-Jiménez, J., Sánchez, A., Fernández, C. et al. Cyclosporine-induced retinal toxic blindness. Bone Marrow Transplant 20, 243–245 (1997). https://doi.org/10.1038/sj.bmt.1700878
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700878
Keywords
This article is cited by
-
Early isolated optic neuropathy caused by cyclosporine
International Ophthalmology (2019)
-
Light and alcohol evoked electro-oculograms in cystic fibrosis
Documenta Ophthalmologica (2006)